Prostate Cancer - Results from #160

Preoperative prostate magnetic resonance imaging does not impact surgical outcomes of radical prostatectomy. November 21, 2024

Comparing the Technological and Intraoperative Performances of Da Vinci xi and DaVinci 5 Robotic Platforms in Patients Undergoing Robotic-Assisted Radical Prostatectomy. November 21, 2024

Prostate Cancer Screening: Common Questions and Answers. November 21, 2024

Repeat Prostate Cancer Screening using Blood-based Risk Prediction or Prostate-specific Antigen in the Era of Magnetic Resonance Imaging-guided Biopsies : A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial. November 21, 2024

Anatomic Factors Associated with Complications After Radical Prostatectomy: A Systematic Review and Meta-analysis. November 21, 2024

Computational analysis of variability and uncertainty in the clinical reference on magnetic resonance imaging radiomics: modelling and performance. November 20, 2024

Prostate-specific antigen kinetics after stereotactic body radiotherapy for localized prostate cancer: A scoping review and meta-analysis. November 20, 2024

Small-molecule disruption of androgen receptor-dependent chromatin clusters. November 20, 2024

A Systematic Review of the Diagnostic Accuracy of Deep Learning Models for the Automatic Detection, Localization, and Characterization of Clinically Significant Prostate Cancer on Magnetic Resonance Imaging. November 20, 2024

Colibactin Exerts Androgen-dependent and -independent Effects on Prostate Cancer. November 20, 2024

Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer. November 20, 2024

Comparison of online adaptive and non-adaptive magnetic resonance image-guided radiation therapy in prostate cancer using dose accumulation. November 19, 2024

Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancer. November 19, 2024

[225Ac]Ac-PSMA for the treatment of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. November 19, 2024

Association between beta-blocker atenolol use and prostate cancer upgrading in active surveillance. November 19, 2024

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer. November 19, 2024

The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer. November 19, 2024

St Vincent’s Hospital to Conduct Head-to-Head Trial with Clarity’s SAR-bisPSMA Diagnostic Product November 18, 2024

Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers. November 18, 2024

HSD3B1, prostate cancer mortality and modifiable outcomes. November 18, 2024

Page 9 of 1447